Events Archives - Page 67 of 128

4 minute read

Eterna Therapeutics And Factor Bioscience Announce New Data on Multi-Cell-Type Therapeutic Approach At American Society Of Gene & Cell Therapy 26th Annual Meeting

May 17, 8:46 AM

Approach is potentially first iPS cell-derived multi-cell-type therapeutic strategy designed to mimic how the human immune system naturally fights disease Presentations to include additional advances in

ERNA

2 minute read

Events
News

‘SoundHound To Showcase Next-Generation Restaurant Voice AI Technology At NRA 2023’

By Happy Mohamed

May 16, 12:58 PM

https://www.soundhound.com/newsroom/press-releases/soundhound-to-showcase-next-generation-restaurant-voice-ai-technology-at-nra-2023/ SoundHound AI, Inc. (NASDAQ:SOUN) (“SoundHound”), a global leader in

SOUN

2 minute read

Las Vegas Room Rates Up 30% Since 2019: Should Investors Roll The Dice On Casino Stocks?

By Wayne Duggan

May 15, 1:56 PM

Gaming stocks have performed well in 2023 as Las Vegas travel trends have normalized and Macau gaming has surged following the lifting of China's COVID-19 restrictions. Casino fundamentals remain positive heading into the summer travel season, according to Bank of America analyst Shaun Kelley.

CZR

5 minute read

Neurocrine Biosciences Presents INGREZZA Capsules Data On Long-Term Improvements And Psychiatric Stability In Patients With Tardive Dyskinesia And Schizophrenia Or Schizoaffective Disorder At The Schizophrenia International Research Society

By Happy Mohamed

May 15, 8:38 AM

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced findings from a post hoc analysis of two long-term studies (KINECT™ 3 and KINECT™ 4) of INGREZZA® (valbenazine) capsules

NBIX

4 minute read

EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses

By Lara Goldstein

May 12, 7:37 PM

This year’s edition of Benzinga’s Psychedelics Capital Conference hosted some of the most knowledgeable panelists and hot-button discussions currently in the space.

BWVI

3 minute read

Amarin Highlights New Data Providing Potential Mechanistic Insight Into Vascepa/Vazkepa Reduction Of Cardiovascular Events

By Happy Mohamed

May 12, 11:02 AM

— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — --Data Further Advances Understanding of VASCEPA/VAZKEPA Potential

AMRN

2 minute read

Nkarta To Present NKX019 Phase 1 Dose Escalation Data At European Hematology Association 2023 Congress And 17th International Conference On Malignant Lymphoma

By Happy Mohamed

May 11, 4:32 PM

Nkarta, Inc. (NASDAQ:NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced that it will present preliminary data from its Phase 1 dose escalation clinical trial of

NKTX

2 minute read

ADC Therapeutics Announces Updated Results From LOTIS-2 Trial To Be Presented At The European Hematology Association 2023 Hybrid Congress

By Happy Mohamed

May 11, 12:36 PM

Poster presentation will highlight durable, long-term responses in relapsed/refractory DLBCL patients treated with ZYNLONTA® ADC Therapeutics SA (NYSE:ADCT) today announced updated results from LOTIS-2, the

ADCT

2 minute read

Novartis To Feature New PNH And CML Scientific Data From Broad Hematology Portfolio At European Hematology Association Annual Meeting

By Happy Mohamed

May 11, 12:19 PM

Updated iptacopan data confirm hemolysis control in paroxysmal nocturnal hemoglobinuria (PNH) patients from Phase III APPLY-PNH and APPOINT-PNH studies Head-to-head data from Phase III ASCEMBL trial reaffirm

NVS

6 minute read

SpringWorks Therapeutics Announces Clinical Data Presentations Of Nirogacestat =In Combination With BCMA-Directed Therapies At The European Hematology Association 2023 Congress

By Happy Mohamed

May 11, 12:17 PM

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, announced today that data from two

GSK